Seattle Genetics, Inc. News Headlines

Get SGEN Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading SGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths
10/15/2014 9:35:00 AM - TheStreet

Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
10/3/2014 9:41:00 AM - TheStreet

Seattle Genetics-Takeda Reveal Impressive Adcetris Data - Analyst Blog
10/1/2014 3:30:00 PM -

Will This Analyst Downgrade Hurt Seattle Genetics (SGEN) Stock Today?
9/30/2014 9:44:00 AM - TheStreet

Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
9/29/2014 9:31:00 AM - TheStreet

Sector Update: Health-Care Shares Sink in Pre-Market Trade
9/29/2014 8:39:13 AM - MT Newswires

Sector Update: Health Care
9/29/2014 8:38:27 AM - MT Newswires

Seattle Genetics, Takeda Report Positive Data From Phase 3 Trial Of ADCETRIS
9/29/2014 6:53:00 AM - RTT News

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog
9/25/2014 6:27:00 PM -

Interesting SGEN Put And Call Options For November 22nd
9/24/2014 12:25:58 PM - BNK Invest

Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog
9/18/2014 7:00:00 PM -

Seattle Genetics, Genmab In New Antibody-Drug Conjugate Collaboration
9/10/2014 12:14:00 PM - RTT News

Seattle Genetics (SGEN) Shares Cross Below 200 DMA
9/5/2014 11:50:13 AM - BNK Invest

Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
8/26/2014 6:44:00 PM -

Risk And Reward Seem Pretty Balanced At Seattle Genetics
8/19/2014 5:21:00 PM - Seeking Alpha

First Week of SGEN October 18th Options Trading
8/19/2014 1:50:18 PM - BNK Invest

Can the Rally in Seattle Genetics (SGEN) Shares Continue? - Tale of the Tape
8/18/2014 9:36:18 AM -

Seattle Genetics (SGEN) Shares Cross Above 200 DMA
8/12/2014 11:38:41 AM - BNK Invest

Seattle Genetics Begins Phase 1 Trial Of SGN-CD70A For NHL And RCC - Quick Facts
8/12/2014 9:10:00 AM - RTT News

AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog
8/5/2014 5:50:00 PM -

Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog
8/4/2014 4:20:00 PM -

ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results
8/1/2014 12:32:00 AM - RTT News

Seattle Genetics Q2 Loss Widens
7/31/2014 5:34:00 PM - RTT News

Seattle Genetics Q2 14 Earnings Conference Call At 4:30 PM ET
7/31/2014 3:06:00 PM - RTT News

Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape
7/22/2014 8:51:00 AM -